Exploring the Potential of Natural Compounds as Anticancer Agents
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Pharmaceutical Science".
Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 3430
Special Issue Editors
Interests: breast cancer; estrogen receptors; tamoxifen resistance
Interests: targeted cancer therapy; apoptosis; metastasis; cancer chemoresistance; pancreatic cancer; breast cancer; lung cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is a pleasure to invite you to contribute to this Special Issue of Life, which aims to collect the most recent information on a diverse range of innovative therapies for the treatment of cancer.
Despite continuous advances in the development of new anticancer drugs, cancer remains a significant threat to human health and one of the leading causes of death worldwide. With the rising number of cancer-related deaths, it has become imperative to develop therapeutic approaches that are effective with minimal cytotoxic side effects and resistance. In recent years, several compounds, such as small molecules, engineered antibodies, immunomodulators, and others, have been approved for cancer treatment. Despite the application of multiple modern and expensive treatments to combat cancer and limit its lethality, the results have not been particularly encouraging.
Recent research suggests a growing interest in using natural compounds in addition to chemotherapy as an adjuvant treatment to enhance the therapeutic index of certain anti-neoplastic drugs. Natural compounds possess a range of advantageous activities, such as promoting good health and aiding in cancer treatment, being an invaluable and practical source of anticancer agents. A positive trend has been shown in using them in preclinical research, inspiring numerous innovative strategies to combat cancer and expedite clinical research.
In addition, due to their unique molecular properties, natural products can provide superior efficacy and safety, as they do not have toxic effects towards normal cells but are more selective against cancer cells.
The aim of this Special Issue is to provide an overview of novel formulations of natural products as a means of treating and preventing cancer, as well as the molecular mechanisms that underscore their anticancer properties.
Dr. Christiana Charalambous
Dr. Christiana M. Neophytou
Dr. Alexandru Vasincu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- chemoprevention
- natural compounds
- cancer signaling pathways
- immunotherapeutics
- molecular mechanisms
- apoptosis
- angiogenesis inhibitors
